COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment

Affiliations

• ¹ Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, A.O.U. "Città della Salute e della Scienza di Torino", Turin, Italy.
• ² Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Ospedale Amedeo di Savoia, ASL TO2, Turin, Italy.
• ³ Department of Internal Medicine, NYU Grossman School of Medicine, New York, USA.
• ⁴ Department of Cardiovascular and Thoracic Surgery, University of Torino, A.O.U. "Città della Salute e della Scienza di Torino", Turin, Italy.
• ⁵ Unit of Microbiology and Virology, Department of Public Health and Pediatric Sciences, University of Torino, A.O.U. "Città della Salute e della Scienza di Torino", Turin, Italy.
• ⁶ Division of Hematology and Medical Oncology, NYU Grossman School of Medicine, Perlmutter Cancer Center, NYU Langone Health, New York, USA.